Assessing the relative efficacy of components of opioid-free anaesthesia in adult surgical patients: protocol for a systematic review and component network meta-analysis.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
29 Oct 2024
Historique:
medline: 31 10 2024
pubmed: 31 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

The rise of opioid-free anaesthesia (OFA) aims to reduce postoperative pain while reducing opioid-related side effects during surgery. However, the various adjuvant agents used in OFA complicate the evaluation of their effectiveness and risks. Recent reviews question the clinical benefits of OFA, highlighting the need for thorough evaluation. This protocol describes a network meta-analysis to compare the effectiveness of OFA with opioid-based anaesthesia and will identify key components for optimal postoperative outcomes. We will perform a systematic search of literature published in English without time restriction in Embase, The Cochrane Library, MEDLINE (via PubMed) and CINAHL, along with Google Scholar for grey literature. The final search will be performed on 1 October 2024. We will include randomised controlled trials with adult patients undergoing surgery with general anaesthesia, excluding preclinical, observational, regional anaesthesia-only and prolonged anaesthesia outside the operating room studies. The primary outcome is postsurgical pain scores, with secondary outcomes including quality of recovery, opioid consumption, adverse effects and long-term events. We will assess bias using the Cochrane risk of bias 2 tool and conduct Bayesian network meta-analyses for pooled estimates. We will report effect estimates as ORs and standardised mean differences with 95% credible intervals and assess certainty using GRADE methodology. Ethics approval is not required for this systematic review. Results will be published in a peer-reviewed journal and presented at national and international anaesthesia and pain management conferences. CRD42024505853.

Identifiants

pubmed: 39477266
pii: bmjopen-2024-089024
doi: 10.1136/bmjopen-2024-089024
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e089024

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: MWH is the Executive Section Editor in Pharmacology with Anesthesia & Analgesia, Editor with Journal of Clinical Medicine, and Editor Frontiers in Physiology. MWH received honorarium for consultancy from IDD Pharma, Medical Developments & PAION. The other authors declare that they have no competing interests.

Auteurs

Amparo Belltall (A)

Perioperative Medicine Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Anesthesiology and Critical Care, Hospital la Fe, Valencia, Spain.

Guido Mazzinari (G)

Perioperative Medicine Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain gmazzinari@gmail.com.
Anesthesiology and Critical Care, Hospital la Fe, Valencia, Spain.
Statistics and Operative Research, Universidad de Valencia, Valencia, Spain.
Euro-Periscope: The Onco-Anaesthesiology Research Group (RG), European Society of Anaesthesiology & Intensive Care (ESA-IC), Brussels, Belgium.

Aisling Ní Eochagáin (A)

Department of Anaesthesiology & Perioperative Medicine, Mater University Hospital, University College, Dublin, Ireland.

Tom Wall (T)

Department of Anaesthesiology & Perioperative Medicine, Mater University Hospital, University College, Dublin, Ireland.

Ary Serpa Neto (A)

Monash University, Melbourne, Victoria, Australia.
Department of Critical Care Medicine, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Oscar Diaz-Cambronero (O)

Perioperative Medicine Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Anesthesiology and Critical Care, Hospital la Fe, Valencia, Spain.

Daniel Sessler (D)

Center for Outcomes Research and Department of Anesthesiology, UTHealth, Houston, Texas, USA.

Donal J Buggy (DJ)

Euro-Periscope: The Onco-Anaesthesiology Research Group (RG), European Society of Anaesthesiology & Intensive Care (ESA-IC), Brussels, Belgium.
Department of Anaesthesiology & Perioperative Medicine, Mater University Hospital, University College, Dublin, Ireland.

Juan Cata (J)

Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Markus W Hollmann (MW)

Department of Anesthesiology, Amsterdam UMC - Locatie AMC, Amsterdam, Noord-Holland, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH